PTC Therapeutics
PTCT
#3037
Rank
A$7.61 B
Marketcap
A$91.28
Share price
0.08%
Change (1 day)
-7.31%
Change (1 year)

PTC Therapeutics (PTCT) - Net assets

Net assets on the balance sheet as of June 2026 : -A$0.24 Billion

According to PTC Therapeutics 's latest financial reports the company has -A$0.24 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

PTC Therapeutics - Net assets on balance sheet (from 2012 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-A$0.31 Billion-82.64%
2024-12-31$-A$1.77 Billion46.94%
2023-12-31$-A$1.21 Billion135.56%
2022-12-31$-A$0.52 Billion-25814.25%
2021-12-31$A$1.98 M-99.68%
2020-12-31$A$0.62 B-26.16%
2019-12-31$A$0.84 B70.51%
2018-12-31$A$0.49 B148.46%
2017-12-31$A$0.20 B20.79%
2016-12-31$A$0.16 B-46.52%
2015-12-31$A$0.31 B-14.93%
2014-12-31$A$0.36 B138.24%
2013-12-31$A$0.15 B-928.77%
2012-12-31$-A$18.48 Million-92.06%
2011-12-31$-A$0.24 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
A$60.10 B-25,466.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
A$29.01 B-12,344.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$0.72 B-404.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$2.18 B-1,023.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.21 B-192.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
A$2.41 B-1,121.15%๐Ÿ‡บ๐Ÿ‡ธ USA